Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Unknown 2Completed 2Terminated 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Stomach Neoplasms 38Pancreatic Neoplasms 11Esophageal Neoplasms 8Biliary Tract Neoplasms 8Colorectal Neoplasms 7Neoplasm Metastasis 3Gastrointestinal Neoplasms 3Esophageal Squamous Cell Carcinoma 3Carcinoma, Non-Small-Cell Lung 3Advanced Solid Tumors 3Neoplasms 2Head and Neck Neoplasms 2Colonic Neoplasms 2Cholangiocarcinoma 2Advanced Non-Small Cell Lung Cancer 2Advanced Gastric Cancer 2Adenocarcinoma 2Uterine Cervical Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Progression Free Survival 1Patients With Advanced or Metastatic Solid Tumors 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Overall Survival 1Nasopharyngeal Carcinoma 1Hand-Foot Syndrome 1Carcinoma, Transitional Cell 1Breast Neoplasms 1Advanced Pancreatic Cancer 1Adenocarcinoma Of Esophagus 1

Interventions

Fluorouracil 128Leucovorin 120Oxaliplatin 101Irinotecan 89Bevacizumab 55Cetuximab 44Capecitabine 40Folfox protocol 29Panitumumab 22Colonoscopy 17Chemotherapy, Adjuvant 16Floxuridine 15Early Intervention, Educational 15Erlotinib Hydrochloride 13Surveys and Questionnaires 11IFL protocol 11Counseling 11Celecoxib 11Immunohistochemistry 10Gemcitabine 10Psychiatric Rehabilitation 9Methods 8Magnetic Resonance Spectroscopy 8Gene Expression Profiling 8Exercise 8Dexamethasone 8sargramostim 7Sorafenib 7Radiotherapy 7Nivolumab 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Colonic Neoplasms × S 1 (combination) × Clear all
NCT00660894 2016-08-03

Tegafur-Uracil and Leucovorin or S-1 in Treating Patients With Stage III Colon Cancer That Has Been Completely Removed by Surgery

Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan

Phase 3 Completed
1,535 enrolled
Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

NCT00569335 2012-11-02

Phase II Trial of Combination Therapy With S-1, Irinotecan, and Bevacizumab (SIRB) in Patients With Unresectable or Recurrent Colorectal Cancer

Taiho Pharmaceutical Co., Ltd.

Phase 2 Completed
52 enrolled
Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡